Limited Cutaneous Systemic Sclerosis - 1 Studies Found
| Completed |
: Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet : Ischemia : 2010-02-19 : Drug: ambrisentan Subjects will receive ambrisentan 5 mg orally once daily or identical placebo pills fo |